According to Cognitive Market Research, the global liver disease diagnostics market size was USD 41548.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 16619.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 12464.46 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 9556.09 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 2077.41 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 830.96 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.
The imaging held the highest liver disease diagnostics market revenue share in 2024.
